Cart
sales@molnova.com
Leucettine L41
CAS No. 112978-84-3
Leucettine L41 ( Leucettine L41; Leucettine-L41; LeucettineL41 )
Catalog No. M10457 CAS No. 112978-84-3
A novel potent cdc2-like kinase (CLKs) and DYRKs inhibitor with IC50 of 40, 35 and 15 nM for DYRK1A, DYRK2 and CLK1, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLeucettine L41
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent cdc2-like kinase (CLKs) and DYRKs inhibitor with IC50 of 40, 35 and 15 nM for DYRK1A, DYRK2 and CLK1, respectively.
-
DescriptionA novel potent cdc2-like kinase (CLKs) and DYRKs inhibitor with IC50 of 40, 35 and 15 nM for DYRK1A, DYRK2 and CLK1, respectively; inhibits the phosphorylation of serine/arginine-rich proteins (SRp), a family of proteins regulating pre-RNA splicing, modulates alternative pre-mRNA splicing in cell-based reporting system; induces mTOR-dependent autophagy, prevents Aβ25-35-induced memory impairments and neurotoxicity in the mouse hippocampus.
-
SynonymsLeucettine L41; Leucettine-L41; LeucettineL41
-
PathwayCell Cycle/DNA Damage
-
TargetCLK
-
RecptorCLK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number112978-84-3
-
Formula Weight307.31
-
Molecular FormulaC17H13N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC(NC2=CC=CC=C2)=N/C1=C\C3=CC=C(OCO4)C4=C3
-
Chemical Name(5Z)-5-(1,3-Benzodioxol-5-ylmethylene)-3,5-dihydro-2-(phenylamino)-4H-imidazol-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fant X, et al. Mol Pharmacol. 2014 Mar;85(3):441-50.
2. Naert G, et al. Eur Neuropsychopharmacol. 2015 Nov;25(11):2170-82.
3. Debdab M, et al. J Med Chem. 2011 Jun 23;54(12):4172-86.
4. Tahtouh T, et al. J Med Chem. 2012 Nov 8;55(21):9312-30.
2. Naert G, et al. Eur Neuropsychopharmacol. 2015 Nov;25(11):2170-82.
3. Debdab M, et al. J Med Chem. 2011 Jun 23;54(12):4172-86.
4. Tahtouh T, et al. J Med Chem. 2012 Nov 8;55(21):9312-30.
molnova catalog
related products
-
Leucettine L41
A novel potent cdc2-like kinase (CLKs) and DYRKs inhibitor with IC50 of 40, 35 and 15 nM for DYRK1A, DYRK2 and CLK1, respectively.
-
CLK inhibitor T3
CLK inhibitor T3 (T3) is a highly potent, selective, and cell-based stable CDC-like kinase (CLK) inhibitor with 0.67, 15 and 110nM for CLK1,2 and 3, respectively.
-
KuWal151
KuWal151 is a potent, selective cdc2-like kinase (CLK) inhibitor with IC50 of 88/510/28 nM for CLK1/2/4, respectively.
